Nucleus RadioPharma
nucleusrad.com
Actively hiring
Biotechnology
APIs & Drug Manufacturing
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Clarity signs a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with Nucleus RadioPharma
Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a
Read more
Report
Nucleus RadioPharma Appoints Former FDA Commissioner Dr. Stephen Hahn as CEO to Scale Patient Access to Radiopharmaceutical Therapies
ROCHESTER, Minn., August 20, 2025--Nucleus RadioPharma, a next-generation contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, today announced the appointment of Dr. Stephen M. Hahn as chief executive officer. H
Read more
Report
Nucleus RadioPharma Expands Radiopharmaceutical Research, Development and Manufacturing Capacity, Addressing Nationwide Supply Chain Constraints
Read more
Report
Nucleus RadioPharma Raises $56 Million To Advance Radiopharmaceutical Technology
Nucleus RadioPharma - the world's first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals - recently announced an oversubscribed $56 million Series A funding round led by Eclipse and GE HealthCare with par
Read more
Report
Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients
Today, Nucleus RadioPharma the world's first fully integrated development, manufacturing, and supply chain organization for radiopha…
Read more
Report
Nucleus RadioPharma Lands $56M Raise
Nucleus RadioPharma says it plans to use the funds to ramp up production of a new form of highly targeted cancer treatment.
Read more
Report
Nucleus RadioPharma draws $56M in series A round to boost manufacture of radiopharmaceuticals
Read more
Report
Nucleus RadioPharma Secures $56 Million Series A Funding to Expand Production of Radiopharmaceutical Treatments for Cancer Patients
Read more
Report
Mayo Clinic's Dr. Geoff Johnson to help lead Nucleus RadioPharma start-up
Jun. 14-ROCHESTER - A familiar face is joining Nucleus RadioPharma, a firm co-founded by Mayo Clinic that is an anchor tenant in the Two Discovery Square facility. Dr. Geoff Johnson, the chair of nucl...
Read more
Report